CAAS Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100
Closed -$32.1K 441
2024
Q2
$32.1K Buy
+100
New +$32.5K 0.01% 182
2024
Q1
Sell
-2,900
Closed -$785K 567
2023
Q4
$785K Buy
2,900
+2,600
+867% +$643K 0.08% 219
2023
Q3
$73.8K Buy
+300
New +$82.1K ﹤0.01% 569
2023
Q1
Sell
-1,900
Closed -$456K 797
2022
Q4
$456K Sell
1,900
-16,700
-90% -$3.74M 0.03% 503
2022
Q3
$3.42M Buy
+18,600
New +$3.71M 0.16% 192

Other funds holding HCA

CAAS Capital Management's HCA Position: Q4 2022 in Review

CAAS Capital Management sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 6,600 shares — an estimated $1.48M sold.

CAAS Capital Management first reported a position in HCA in Q3 2022 and held it in 1 quarter. The position peaked at $1.21M in Q3 2022. 962 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • CAAS Capital Management reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 6,600 HCA Healthcare shares in Q4 2022, an estimated $1.48M.
  • CAAS Capital Management first reported a position in HCA Healthcare in Q3 2022 and held it in 1 quarter.
  • CAAS Capital Management's HCA Healthcare position peaked at $1.21M in Q3 2022.
  • 962 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.